 |
MorphoSys AG
MOR
|
1.75 |
- |
2.43 % |
$ 254 M |
Germany |
 |
Aligos Therapeutics
ALGS
|
30.2 |
$ 6.4 |
- |
$ 63.3 M |
USA |
 |
Amphastar Pharmaceuticals
AMPH
|
1.73 |
$ 21.41 |
- |
$ 1 B |
USA |
 |
I-Mab
IMAB
|
94.1 |
- |
- |
$ 866 M |
China |
 |
Aeglea BioTherapeutics
AGLE
|
489 |
- |
- |
$ 1.01 B |
USA |
 |
Midatech Pharma plc
MTP
|
137 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 |
- |
- |
$ 40.3 B |
USA |
 |
Aptorum Group Limited
APM
|
105 |
$ 0.9 |
-2.33 % |
$ 6.62 M |
China |
 |
Genfit SA
GNFT
|
1.96 K |
- |
2.54 % |
$ 160 B |
France |
 |
ACADIA Pharmaceuticals
ACAD
|
3.33 |
$ 21.96 |
- |
$ 3.64 B |
USA |
 |
Cardiff Oncology
CRDF
|
196 |
$ 1.72 |
- |
$ 115 M |
USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Advaxis
ADXS
|
144 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
AIkido Pharma
AIKI
|
0.935 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Esperion Therapeutics
ESPR
|
1.39 |
$ 1.91 |
- |
$ 397 M |
USA |
 |
Ampio Pharmaceuticals
AMPE
|
106 |
- |
-11.43 % |
$ 502 K |
USA |
 |
Институт стволовых клеток человека
ISKJ
|
2.61 |
- |
- |
- |
Russia |
 |
Aeterna Zentaris
AEZS
|
7.87 |
- |
5.93 % |
$ 314 M |
Canada |
 |
Applied Therapeutics
APLT
|
54.1 |
- |
- |
$ 8.42 M |
USA |
 |
Aptinyx
APTX
|
204 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
AgeX Therapeutics
AGE
|
0.099 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Aravive
ARAV
|
6.61 |
- |
-13.39 % |
$ 1.45 M |
USA |
 |
Aridis Pharmaceuticals
ARDS
|
1.34 |
- |
17.91 % |
$ 11.1 M |
USA |
 |
BioNTech SE
BNTX
|
35.7 |
$ 105.46 |
- |
$ 27.2 B |
Germany |
 |
Heron Therapeutics
HRTX
|
1.28 |
$ 1.19 |
- |
$ 198 M |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
65.5 |
- |
- |
$ 26.5 M |
USA |
 |
ImmuCell Corporation
ICCC
|
2.1 |
$ 8.36 |
- |
$ 75.5 M |
USA |
 |
Aquestive Therapeutics
AQST
|
10.5 |
$ 4.08 |
- |
$ 436 M |
USA |
 |
Arcutis Biotherapeutics
ARQT
|
9.15 |
$ 23.26 |
- |
$ 2.96 B |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
11.2 |
- |
- |
$ 7.46 M |
Israel |
 |
Autolus Therapeutics plc
AUTL
|
4.27 |
$ 1.44 |
- |
$ 383 M |
Britain |
 |
Innate Pharma S.A.
IPHA
|
14.7 |
$ 1.41 |
- |
$ 235 M |
France |
 |
AstraZeneca PLC
AZN
|
2.17 |
- |
- |
$ 96.9 B |
Britain |
 |
Jaguar Health
JAGX
|
0.0831 |
$ 0.39 |
-0.18 % |
$ 910 K |
USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
759 |
$ 2.91 |
- |
$ 4.79 M |
Israel |
 |
KalVista Pharmaceuticals
KALV
|
17 |
$ 19.63 |
- |
$ 1.06 B |
Britain |
 |
BioDelivery Sciences International
BDSI
|
1.85 |
- |
-4.8 % |
$ 255 M |
USA |
 |
Kamada Ltd.
KMDA
|
2.61 |
$ 8.28 |
- |
$ 260 M |
Israel |
 |
BeiGene, Ltd.
BGNE
|
66.4 |
- |
0.49 % |
$ 251 B |
Cayman-islands |